After getting crushed by bad data, Zynerba says its cannabis-based drug worked on Fragile X ...

Less than two months since a pair of mid-stage setbacks crushed its stock price, researchers at Zynerba $ZYNE say they had better results from a ...

read more here
Delivered by @can_nab_is